Protara Therapeutics(TARA) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update NEW YORK, May 8, 2025 – Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. "We have made significant progress thus far in 2025, notably with the recent presentation of positive interim results ...